Examkin

Soru

Zorluk: OrtaPediatric Neurologic Disorders

A 6-month-old girl is brought to the pediatric emergency department by her parents due to worsening weakness and poor feeding over the past three days. Her parents report that she previously breastfed vigorously and was able to roll from front to back, but she has progressively lost these abilities. Additionally, she has not passed a stool in five days. The family lives on an older rural property and recently began excavating soil to build a large garden. On physical examination, the infant appears lethargic. Her temperature is 37.1°C (98.8°F), heart rate is 110/min, and respiratory rate is 28/min. Neurological evaluation reveals bilateral ptosis, sluggish pupillary light reflexes, and a weak gag reflex. There is profound generalized hypotonia with marked head lag, and deep tendon reflexes are absent bilaterally. Which of the following is the most appropriate initial treatment for this patient?

  1. A
    Intravenous equine-derived botulism antitoxin
  2. B
    Intravenous ampicillin and cefotaxime
  3. Intravenous human-derived botulism immune globulinCevap
  4. D
    Intravenous immunoglobulin (IVIG)
  5. E
    Observation and outpatient physical therapy

Cevap

Intravenous human-derived botulism immune globulin
The correct answer is intravenous human-derived botulism immune globulin. This infant's presentation of severe constipation, poor feeding, bilateral ptosis, sluggish pupillary reflexes, and descending flaccid paralysis is highly characteristic of infant botulism. The condition is caused by the ingestion of Clostridium botulinum spores, which are commonly found in environmental dust and soil (consistent with the family's recent excavation). Because infants have an immature intestinal microbiome, these spores germinate in the gastrointestinal tract and continuously produce neurotoxin. The neurotoxin irreversibly inhibits acetylcholine release at the presynaptic neuromuscular junction. The definitive and immediate treatment is human-derived botulism immune globulin (BIG-IV). This therapy neutralizes circulating toxin before it can bind to nerve endings, significantly reducing the severity of illness, the need for mechanical ventilation, and the length of hospital stay.

Adım Adım Çözüm

1
Identify the key clinical syndrome based on the infant's presentation.
The patient has an acute onset of descending flaccid paralysis (ptosis, sluggish pupils, poor gag reflex, head lag) preceded by severe constipation.
Recognizing the sequence of autonomic dysfunction (constipation) followed by descending cranial-to-caudal paralysis is crucial for differentiating this from other causes of pediatric weakness.
2
Determine the most likely etiology given the age and environmental exposures.
The clinical picture combined with exposure to excavated soil strongly points to infant botulism caused by the ingestion of Clostridium botulinum spores.
Infant botulism occurs when environmental spores (from soil, dust, or honey) germinate in the infant's immature gastrointestinal tract and produce neurotoxin in situ.
3
Select the appropriate targeted and safe therapy for this specific diagnosis.
The correct treatment is human-derived botulism immune globulin (BIG-IV).
BIG-IV safely neutralizes circulating toxin in infants, whereas equine antitoxin poses severe hypersensitivity risks, and antibiotics can lyse bacteria to release more toxin.

Anahtar Kavram

Infant botulism presents with severe constipation followed by symmetric descending flaccid paralysis and bulbar palsies. It is caused by the ingestion of environmental spores (soil, dust, honey) and must be treated immediately with human-derived botulism immune globulin.
Bu soruyu puanla

Konular

Pediatric Neurologic Disorders

Bu konudan daha fazla soru